Research Tracker›Biomarker Atlas›Marker Pages›Mean Nocturnal Baseline Impedance

Mean Nocturnal Baseline Impedance: biomarker evidence

Mean Nocturnal Baseline Impedance appears in 1 entry of the OSMF biomarker atlas, covering GERD (Gastroesophageal Reflux Disease). Across those entries it is reduced in 1. It is currently reported in a single condition in this atlas; cross-condition comparison will be added as the dataset grows. Each row below links to a page with the comparison group, associated symptoms, test details and primary citation.

GERD (Gastroesophageal Reflux Disease)

Where Mean Nocturnal Baseline Impedance is reported

ConditionDirectionCompared againstAssociated symptomsSource
GERD (Gastroesophageal Reflux Disease)↓ reducedhealthy asymptomatic volunteers, patients with reflux hypersensitivity, and patients with functional heartburn—Hoshikawa et al. 2020

Frequently asked questions

In which conditions is Mean Nocturnal Baseline Impedance altered?

In the OSMF atlas Mean Nocturnal Baseline Impedance is reported in GERD (Gastroesophageal Reflux Disease). It is reduced in 1 across 1 entries.

Is there a standard clinical test for Mean Nocturnal Baseline Impedance?

The atlas entries for Mean Nocturnal Baseline Impedance do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.

Is one abnormal Mean Nocturnal Baseline Impedance result diagnostic?

No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.

Cite this page

Open Source Medicine Foundation. (2026). Mean Nocturnal Baseline Impedance across conditions: biomarker evidence. OSMF Research Tracker. Retrieved November 21, 2026, from https://research.opensourcemed.info/biomarkers/markers/mean-nocturnal-baseline-impedance.html

Last reviewed: 2026-10-08 · Browse: Biomarker Index · All marker pages · Biomarker Atlas

Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.